You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.

OLAP - tablet

Cancer Type: Gynecologic, Ovary      Intent: Adjuvant, Curative, Palliative
Regimen Category: Evidence-Informed
Funding:
Exceptional Access Program
    olaparib (tablet) - For the maintenance treatment of BRCA-mutated, high grade epithelial ovarian, fallopian tube, or primary peritoneal cancer in adult patients, with specific criteria

You might also be interested in